Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs

Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)

European Journal of Human Genetics ◽

10.1038/s41431-021-00969-9 ◽

2021 ◽

Author(s):

Maja Matic ◽

Marga Nijenhuis ◽

Bianca Soree ◽

Nienke J. de Boer-Veger ◽

Anne-Marie Buunk ◽

...

Keyword(s):

Drug Interaction ◽

DRUG INTERACTION WORKING GROUP : JAPAN PHARMACEUTICAL MANUFACTURERS ASSOCIATION

10.2133/dmpk.14.supplement_150 ◽

1999 ◽

Vol 14 (supplement) ◽

pp. 150-151

Author(s):

Satoshi Kobayashi

Keyword(s):

Drug Interaction ◽

Working Group ◽

Pharmaceutical Manufacturers

Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment

10.1124/dmd.120.000055 ◽

2020 ◽

Vol 49 (1) ◽

pp. 94-110

Author(s):

Simon G. Wong ◽

Diane Ramsden ◽

Shannon Dallas ◽

Conrad Fung ◽

Heidi J. Einolf ◽

...

Keyword(s):

Risk Assessment ◽

Cytochrome P450 ◽

Drug Interaction ◽

Working Group ◽

Time Course ◽

Model Fitting ◽

Regulatory Agencies ◽

Cytochrome P450 Induction ◽

DRUG INTERACTION WORKING GROUP: HAB DATABASE

10.2133/dmpk.14.supplement_148 ◽

1999 ◽

Vol 14 (supplement) ◽

pp. 148-149

Author(s):

T. Ikeda

Keyword(s):

Drug Interaction ◽

Considerations from the IQ Induction working group in response to drug-drug interaction guidances from regulatory agencies

10.1016/j.dmpk.2018.09.055 ◽

2019 ◽

Vol 34 (1) ◽

pp. S11

Author(s):

Niresh Hariparsad

Keyword(s):

Drug Interaction ◽

Working Group ◽

Regulatory Agencies ◽

Correction to “Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro CYP Induction Studies Including Impact on Drug Interaction Risk Assessment”

10.1124/dmd.120.000055err ◽

2021 ◽

Vol 49 (4) ◽

pp. 344-344

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Working Group ◽

Time Course ◽

Model Fitting ◽

Regulatory Agencies ◽

Cyp Induction ◽

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)

European Journal of Human Genetics ◽

10.1038/s41431-021-00920-y ◽

2021 ◽

Author(s):

Maja Matic ◽

Marga Nijenhuis ◽

Bianca Soree ◽

Nienke J. de Boer-Veger ◽

Anne-Marie Buunk ◽

...

Keyword(s):

Drug Interaction ◽

Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control

10.1124/dmd.116.074567 ◽

2017 ◽

Vol 45 (10) ◽

pp. 1049-1059 ◽

Cited By ~ 18

Author(s):

Niresh Hariparsad ◽

Diane Ramsden ◽

Jairam Palamanda ◽

Joshua G. Dekeyser ◽

Odette A. Fahmi ◽

...

Keyword(s):

Drug Interaction ◽

Working Group ◽

Positive Control ◽

Regulatory Agencies ◽

Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance

10.1124/dmd.118.081927 ◽

2018 ◽

Vol 46 (9) ◽

pp. 1285-1303 ◽

Cited By ~ 8

Author(s):

Jane R. Kenny ◽

Diane Ramsden ◽

David B. Buckley ◽

Shannon Dallas ◽

Conrad Fung ◽

...

Keyword(s):

Drug Interaction ◽

Clinical Relevance ◽

Working Group ◽

Regulatory Agencies ◽

In Vitro Response ◽

Response Thresholds ◽

Evaluation of the time-course of CYP Induction and impact on drug interaction risk assessment from the IQ Induction working group

10.1016/j.dmpk.2018.09.146 ◽

2019 ◽

Vol 34 (1) ◽

pp. S40

Author(s):

Niresh Hariparsad ◽

Heidi Einolf ◽

David Buckley ◽

Shannon Dallas ◽

Josh Dekeyser ◽

...

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Working Group ◽

Time Course ◽

Cyp Induction